Home Page

Emergent is dedicated to one simple
mission—to protect and enhance life.

As a global specialty life sciences company,
Emergent is  focused on providing specialty products
for civilian and military populations that address
intentional and naturally emerging public health threats.

Learn More

Emergent BioSolutions
Receives FDA Approval
for Large-Scale Manufacturing
of BioThrax in Building 55

LEARN MORE ▶

Emergent BioSolutions
Spins-Off off Its
Biosciences Business
Aptevo Therapeutics

LEARN MORE ▶

Our corporate social
responsibility efforts
are a key part of our
mission to protect and
enhance life for millions
around the world.

VIEW OUR ONLINE
CSR REPORT
 ▶
>

Emergard Auto-Injector Platform
for Nerve Agent Antidote Delivery
Selected by U.S. Department of
Defense and Battelle
for Testing and Development

LEARN MORE ▶

Meet Us

  • CPhI Worldwide

    CPhI Worldwide
    Barcelona, Spain
    October 4-6

     

  • BioProcess International Conference

    BioProcess International
    Boston, MA
    October 4-7

     

  • Investor Relations

    Check back soon for upcoming investor conferences

     

Price $27.06 -0.57 (-2.06%)
 Aug 24 2016 4:02PM

REFRESH